Moderna to start Covid vaccine trials on children as young as six months old


The company produces one of the three vaccines currently authorised for use in the US — the other two being Pfizer and Johnson & Johnson.

Moderna will be the first manufacturer to test a vaccine on infants and young children.

Nearly 7,000 children across the US and Canada will be enrolled in the study which will be structured in two parts.

The first will focus on finding an appropriate dosage.

“Children often need lower doses of vaccines than adults and we want to make sure we find the best dose that increases their immunity,” Dr. Jacqueline Miller, a pediatrician and Moderna’s therapeutic area head for infectious diseases, told ABC’s Good Morning America.

She added that the first age group to start in the trial will be children ages six to 11, followed by children ages two to six and then children six months to two years old. Younger children may receive a lower dosage.


Source link

Related posts